Prime Capital Investment Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346K | Sell |
1,203
-704
| -37% | -$202K | ﹤0.01% | 718 |
|
|
2025
Q1 | $588K | Buy |
1,907
+477
| +33% | +$147K | 0.01% | 628 |
|
|
2024
Q4 | $505K | Buy |
1,430
+54
| +4% | +$19.1K | 0.01% | 567 |
|
|
2024
Q3 | $493K | Sell |
1,376
-20
| -1% | -$7.17K | 0.01% | 591 |
|
|
2024
Q2 | $445K | Buy |
1,396
+384
| +38% | +$122K | 0.01% | 606 |
|
|
2024
Q1 | $232K | Buy |
1,012
+6
| +0.6% | +$1.38K | ﹤0.01% | 870 |
|
|
2023
Q4 | $221K | Buy |
1,006
+44
| +5% | +$9.68K | ﹤0.01% | 847 |
|
|
2023
Q3 | $217K | Sell |
962
-9
| -0.9% | -$2.03K | ﹤0.01% | 666 |
|
|
2023
Q2 | $214K | Buy |
+971
| New | +$214K | ﹤0.01% | 690 |
|